(Q47713426)

English

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Stud

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Stud (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Andriole GL

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Guess HA

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Epstein JI

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Wise H

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Kadmon D

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Crawford ED

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Hudson P

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Jackson CL

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Romas NA

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Patterson L

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Cook TJ

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Waldstreicher J

12

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

language of work or name

0 references

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

52

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

195-201; discussion 201-2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of finasteride on prostate-specific antigen density

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on prostate specific antigen: review of available data

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. The Finasteride PSA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Likelihood ratios with confidence: sample size estimation for diagnostic test studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal screening for prostate cancer with prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting results of prostate-specific antigen testing for early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900184-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00184-8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9697781

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47713426&oldid=1521684058"